Opioid maker, Endo International, will pay out millions as the maker of generic and branded opioids including Percocet and Endocet, and made OpanaER, which was withdrawn from the market in 2017. 

Montana is one of dozens of states that reached a legal agreement alleging that Endo falsely promoted the benefits of Opana ER’s so-called abuse-deterrent formulation, which did nothing to deter oral abuse and led to deadly outbreaks of Hepatitis and HIV due to its widespread abuse via injection.

“Hundreds of Montanans have died and thousands more are struggling with addiction because of deceptive marketing and other actions taken by opioid manufacturers. Endo was one of those companies, falsely saying its opioids deterred abuse,” Attorney General Knudsen said. “This settlement will ban them from advertising opioids and force them to pay $450 million to states like Montana to support treatment and prevention for our citizens,” according to AG Knudsen.

Under the agreement, Endo and its lenders would provide up to $450 million to participating states and local governments, ban promotion of the company’s opioids, and require it to turn over millions of documents related to its role in the opioid crisis for publication in a public online archive.